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Abstract
Background: Embarrassment can be a considerable problem for patients with essential tremor (ET) and is a major
motivator for treatment. Depression is also a common feature of ET; as many as 35 % of patients report moderate
to severe depressive symptoms. Our goal was to assess the associations between these motor and psychosocial
factors (tremor, depression, embarrassment) in ET, with a particular interest in more fully assessing the possible
association between depression and embarrassment.
Methods: Ninety one ET cases (age 70.4 ± 12.8 years) enrolled in a prospective, clinical-epidemiological study.
Depressive symptoms were assessed with the Center for Epidemiological Studies Depression Scale (CESD-10, 0–30
[maximum]), embarrassment, with the Essential Tremor Embarrassment Assessment (ETEA, 0–70 [maximum]), and
action tremor, with a detailed in-person neurological examination.
Results: Higher CESD-10 score was significantly associated with higher ETEA score (p = 0.005), but not with
increasing tremor severity (p = 0.94). In stratified analyses, cases with no or minimal depressive symptoms had the
lowest ETEA scores, cases with moderate depressive symptoms had intermediate ETEA scores, and cases with
severe depressive symptoms had the highest ETEA scores (p = 0.01). Furthermore, at each level of tremor severity,
cases with more depressive symptoms had more embarrassment.
Conclusions: Depressive symptoms seem to be more than a secondary response to the tremor in ET; they seem to
amplify the level of embarrassment and, in addition to their own importance, seem to be a driver of other
important clinical outcomes. Earlier treatment of depressive symptoms in ET patients could lessen the burden of
secondary embarrassment.
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Background
According to some estimates, 60 % of essential tremor
(ET) patients report embarrassment surrounding their
tremor [1]. Embarrassment, classified as a “self-conscious”
emotion along with shame and guilt, and in contrast to
“basic” emotions such as anger and joy [2], often arises
when someone violates a social rule or expectation [3].
Embarrassment is associated with autonomic reactivity in-
cluding increased heart rate, blood pressure, and sweating
and behavioral reactions including gaze avoidance, regret
signaling, and avoidance of others [3]. Embarrassment
about tremor is a considerable problem for patients with
ET [1, 4–7]. It is one of the two main motivators for ET
patients to initiate medical therapy [1, 4–6] and it is a par-
ticularly strong predictor of receptivity to deep brain
stimulation (DBS) surgery among patients with ET [8].
Moreover, feelings of embarrassment can lead to avoid-
ance of social situations and social isolation [9]. Indeed,
handling embarrassment and the social effects of tremor
has been highlighted by ET patients as one of the top
issues not being addressed in their care [10].
Depressive symptoms and depression have been associ-
ated with ET in numerous case–control studies [11–17];
according to some estimates, as many as 35 % of patients
report moderate to severe depressive symptoms [17].
Similar to embarrassment, depression in ET is often
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viewed as a secondary response to the disabling condition
[11, 14]. Overall; however, depression has not been well
studied in ET [11], and there is emerging evidence that
depression may be a primary feature of the disease,
preceding motor symptoms [18]. This suggests that de-
pression itself could drive other clinical outcomes in ET,
such as embarrassment, rather than representing a passive
response to the motor symptoms.
Although tremor, embarrassment, and depression may all
occur in ET, and likely impact one another, the associations
among them have not been the subject of previous analyses.
The goal of these analyses was to assess the associations
between these motor and psychosocial factors (ie, tremor,
embarrassment, and depression) in individuals with ET,
with a particular interest in more fully assessing the pos-
sible association between depression and embarrassment.
Methods
Participants and evaluation
As described previously, ET cases were enrolled in a
clinical-epidemiological study of the epidemiology of
movement disorders at Columbia University Medical
Center (CUMC) [19, 20]. The large majority of cases were
derived from two sources: (1) a computerized billing
database of ET patients at the Neurological Institute of
New York, CUMC, and (2) advertisements to members of
the International Essential Tremor Foundation. One-
hundred-forty-one cases were enrolled (2009–2014).
During that time period, a formal assessment of embar-
rassment was added. Ninety-one cases were enrolled after
the embarrassment assessment was added. Cases had all
received a diagnosis of ET from their treating neurologist
and were confined to a geographical area within 2 h driv-
ing distance of CUMC. Prior to enrollment, one of the au-
thors (E.D.L.) reviewed the office records of identified
patients; those with diagnoses of or physical signs consist-
ent with other movement disorders were excluded.
The CUMC Internal Review Board approved of all study
procedures. Written informed consent was obtained upon
enrollment. Analysis of data was also approved by the
Internal Review Board at Yale School of Medicine.
During the in-person evaluation, the trained research
worker administered a series of structured clinical ques-
tionnaires (demographics, clinical features, medications,
family history). The research worker also administered the
Center for Epidemiological Studies Depression Scale
(CESD-10) (0–30 [higher scores indicate greater depres-
sive symptoms]) [21]. The CESD is a self-report measure
of 10 questions about the frequency of experiencing (0 to
3 for each item) different depressive symptoms. It is a reli-
able and valid instrument [22]. In addition, the Essential
Tremor Embarrassment Assessment (ETEA), an assess-
ment of tremor-related embarrassment (range = 0–70
[maximal embarrassment]) [15] was administered to ET
patients [4]. The ETEA, which is a valid and reliable
instrument [4], comprises 14 questions that assess overall
embarrassment and its effects on the patient’s desire for
tremor medication, as well as embarrassment in a variety
of situations (eg, eating in public, speaking in front of a
group, social situations). Each item is rated from 0 to 5,
with higher scores indicating greater embarrassment [4].
All cases underwent a standardized videotaped tremor
examination, which included tests of postural and kinetic
tremors and assessments for the presence of other involun-
tary movements. The aim was to use the videotape to care-
fully validate ET diagnoses using rigorous research-grade
diagnostic criteria [23]. Thus, each videotape was reviewed
by a senior neurologist specializing in movement disorders
(E.D.L.) who confirmed the ET diagnoses using Washing-
ton Heights-Inwood Genetic Study of ET (WHIGET) diag-
nostic criteria (moderate or greater amplitude kinetic
tremor [tremor rating ≥2] during three or more tests or a
head tremor, in the absence of Parkinson’s disease, dystonia
or another cause) [23]. The neurologist also rated postural
and kinetic tremor (range = 0–3) during 12 videotaped tests
and computed a total tremor score (range = 0–36).
Statistical analyses
Data were analyzed in SPSS (Version 22.0). Chi-square
tests were used to assess associations within categorical
data. Total tremor score, ETEA score and CESD-10
score were all normally distributed (Kolmogorov-Smir-
nov Test p values = 0.67, 0.70, 0.35, respectively); hence,
parametric tests (eg, Pearson’s r) were used when asses-
sing these variables.
Several CESD-10 cut-offs have been recommended for
depression, including a score ≥10 [21], and a more
conservative score ≥20 [24]. To incorporate both sets of
recommendations, as in a prior set of analyses [25], we
divided cases into three groups based on their CESD-10
score: 0–9 (no or minimal depressive symptoms), 10–19
(moderate depressive symptoms), ≥20 (severe depressive
symptoms). Scores > 20 have high sensitivity and specifi-
city for the diagnosis of Major Depressive Disorder as
defined in the DSM [26–28]. To derive strictly mathem-
atical cut-points, CESD-10 scores were also stratified
into quartiles (≤3, 4–7, 8–12, ≥13).
Linear regression models were used to assess the asso-
ciations between variables.
Results
The 91 ET cases had a mean age of 70.4 ± 12.8 years and a
mean tremor duration of 36.9 ± 18.7 years. The mean
CESD-10 score was 9.5 ± 6.2 (range = 0–26) (Table 1), with
47 (51.6 %) having no or minimal depressive symptoms, 37
(40.7 %) having moderate depressive symptoms and 7
(7.7 %) having severe depressive symptoms. Six (6.6 %)
cases had CESD-10 scores > 20, of whom one (1.1 %) was
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also taking an antidepressant medication. The mean ETEA
score was 24.2 ± 16.9 (range = 0–61).
Higher total tremor score was associated with higher
ETEA score (Pearson’s r = 0.27, p = 0.016 and see Fig. 1);
however, higher total tremor score was not associated with
higher CESD-10 score (Pearson’s r = 0.008, p = 0.94).
Higher CESD-10 score was associated with higher
ETEA score (Pearson’s r = 0.29, p = 0.005, Fig. 2). Fur-
thermore, cases with no or minimal depressive symp-
toms had the lowest ETEA scores, cases with moderate
depressive symptoms had intermediate ETEA scores,
and cases with severe depressive symptoms had the
highest ETEA scores (p = 0.01, Table 2). Similarly, there
was a significant association between CESD-10 score
quartile and ETEA score (p = 0.001, Table 2).
At each level of tremor severity (ie, at each total tremor
score), higher level of depressive symptoms was associated
with more embarrassment; thus, cases in the lowest CESD-
10 quartile (ie, fewest depressive symptoms) had the lowest
levels of embarrassment and cases in the highest CESD-10
quartile (ie, most depressive symptoms) had the highest
levels of embarrassment (Fig. 1).
Cases with severe depressive symptoms (CESD-10 score
≥20) had higher ETEA scores than those with fewer depres-
sive symptoms, despite the fact that they had similar levels
of tremor severity (Table 3). Indeed, mean level of embar-
rassment was 50 % higher in cases with severe depressive
symptoms than those with no or minimal depressive symp-
toms (31.4 vs. 19.9, Table 3) despite nearly identical total
tremor scores (19.0 vs. 19.6, Table 3). This was associated
with greater medication usage; 7 of 7 (100 %) cases with se-
vere depressive symptoms had taken medication for tremor
vs. 28/47 (59.6 %) of those with no or minimal depressive
symptoms (chi-square test = 4.37, p = 0.037, Table 3).
In a subgroup analysis of 58 patients with family history
of ET or tremor, higher CESD-10 score was associated
with higher ETEA score (Pearson’s r = 0.30, p = 0.02). Fur-
thermore, cases with no or minimal depressive symptoms
had the lowest ETEA scores (n = 28, 21.9 ± 17.6), cases
with moderate depressive symptoms had intermediate
ETEA scores (n = 25, 28.6 ± 16.4), and cases with severe
depressive symptoms had the highest ETEA scores (n = 5,
36.8 ± 18.2) (linear regression analysis, p = 0.04).
Discussion
Tremor, depression, and embarrassment may co-occur in
many ET patients, making this an important constellation
of motor and psychosocial factors. Hence, it is surprising
that the associations between these factors have not been
delineated previously. In the current study, higher depres-
sive symptom scores were associated with significantly
greater levels of embarrassment (p = 0.005). Indeed, cases
with no or minimal depressive symptoms had the lowest
embarrassment scores, cases with moderate depressive
symptoms had intermediate embarrassment scores, and
cases with severe depressive symptoms had the highest
embarrassment scores (p = 0.01). Cases with severe
depressive symptoms (CESD-10 score ≥20) had higher
ETEA scores than those with fewer depressive symptoms,
despite the fact that they had similar levels of tremor
severity. Indeed, level of embarrassment was 50 % higher
in cases with severe depressive symptoms than those with
minimal depressive symptoms despite nearly identical
total tremor scores.
As noted above, at each level of tremor severity, cases
who had more depressive symptoms had more embarrass-
ment. While it is conceivable that greater embarrassment
could lead to more depression, it is more plausible that
the converse is the case, that is, that depressive symptoms
are amplifying the level of embarrassment. The CESD-10
scale measures the full range of depressive symptoms
including somatic symptoms such as poor appetite, de-
creased energy, psychomotor retardation, and insomnia.
Embarrassment is unlikely to be the direct cause of any of
Table 1 Demographic and clinical characteristics of 91 ET cases
Age in years 70.4 ± 12.8
(range = 33–96)
Female gender 47 (51.6)
Education in years 16.2 ± 2.8
Non-Hispanic white race 86 (94.5)
Age of onset of tremor in years 37.7 ± 18.1
Tremor duration in years 36.9 ± 18.7
Family history of:
ET 28 (30.8)
ET or tremor 58 (63.7)
Total tremor score 20.6 ± 5.9
Head (neck) tremor on examination 32 (35.2)
Voice tremor on examination 24 (26.4)
CESD-10 score 9.5 ± 6.2
(range = 0–26)
CESD-10 score
0–9 (no or minimal depressive symptom category) 4.7 ± 2.7 (n = 47)
10–19 (moderate depressive symptom category) 13.0 ± 2.5 (n = 37)
≥ 20 (severe depressive symptom category) 23.1 ± 2.3 (n = 7)
CESD-10 score
≤ 3 (lowest quartile) 1.4 ± 1.2
4–7 (second quartile) 5.4 ± 1.2
8–12 (third quartile) 10.2 ± 1.2
≥ 13 (highest quartile) 17.1 ± 4.1
ETEA score 24.2 ± 16.9
(range = 0–61)
Values represent mean ± standard deviation or number (percentage)
CESD-10 (Center for Epidemiological Studies Depression Scale), ETEA (Essential
Tremor Embarrassment Assessment)
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these depressive symptoms. Depression often acts as an
amplifier of related symptoms in psychiatric disorders. De-
pression is associated with an increase in the distress and
disability associated with chronic pain [29]. Self-conscious
emotions including shame, guilt, and embarrassment in-
crease, often dramatically, during an episode of major de-
pressive disorder [30].
More broadly, these data also suggest that depressive
symptoms are a driver of other important clinical out-
comes in ET rather than merely a passive, secondary
response to tremor. Depressive symptoms and/or depres-
sion have been reported as more prevalent in ETcases than
controls in numerous studies [11–17]. Indeed, in the
current study, more than half of the cases had moderate or
severe depressive symptoms. Despite its high prevalence,
the causes, effects and natural history of depression in ET
have not been studied in any detail [11], although in a prior
set of analyses, we showed that depressive symptoms were
a strong predictor of tremor-related quality of life in ET
[25]. Furthermore, its relationship to the motor features of
ET may be complex. Emerging evidence suggests that
depression may even be a primary feature of ET, preceding
the motor features [18]. This finding has precedent in
other movement disorders, including Huntington’s disease
and Parkinson’s disease [31, 32]. Studies that examine the
clinical correlates of depression and its relationships with
other disease features in ET are therefore of importance.
Fig. 1 ETEA score by total tremor score in each CESD-10 quartile. At each level of tremor severity (ie, at each total tremor score), higher level of
depressive symptoms was associated with more embarrassment; thus, cases in the lowest CESD-10 quartile (ie, fewest depressive symptoms) had the
lowest levels of embarrassment and cases in the highest CESD-10 quartile (ie, most depressive symptoms) had the highest levels of embarrassment
Fig. 2 ETEA score by CESD-10 score. Higher CESD-10 score was asso-
ciated with higher ETEA score (Pearson’s r = 0.29, p = 0.005)




0–9 (no or minimal depressive symptoms) 19.9 ± 16.4
10–19 (moderate depressive symptoms) 28.4 ± 16.4
≥ 20 (severe depressive symptoms) 31.4 ± 17.6
p = 0.01a
CESD-10 score quartiles
≤ 3 (lowest quartile) 15.3 ± 12.2
4–7 (second quartile) 20.2 ± 17.3
8–12 (third quartile) 26.6 ± 16.5
≥ 13 (highest quartile) 31.6 ± 16.7
p = 0.001b
Values represent mean ± standard deviation or number (percentage)
CESD-10 (Center for Epidemiological Studies Depression Scale), ETEA
(Essential Tremor Embarrassment Assessment)
aLinear regression analysis with ETEA score as dependent variable and CESD
score category as the independent variable
bLinear regression analysis with ETEA score as dependent variable and CESD
score quartile as the independent variable
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One clinical implication of the current findings is that
they increase the importance of treating depressive
symptoms in patients with ET as, in addition to reducing
depressive symptoms, it may reduce embarrassment as
well. Embarrassment is a considerable problem for ET
patients [1, 4–6]. It is one of the two main motivators
for initiating medical therapy [1, 4–6] and can further
lead to avoidance of social situations and social isolation
[9]. Indeed, handling the embarrassing social effects of
tremor has been highlighted by patients as one of the
top issues not being addressed in their current care [10].
While the effect of depression treatment has not been
specifically studied in ET patients, the effect size for the
treatment of depressive symptoms with antidepressant
medication in patients with Parkinson’s disease is mod-
erate [33]. The findings of the current study also suggest
that the treatment of depression with psychotherapy in
patients with ET should assess and target embarrassment
as well as the more usual depressive symptoms. In ET
patients with depression and prominent embarrassment,
referral to a psychotherapist who utilizes a symptom-
based therapy method such as Cognitive-Behavioral
Therapy (CBT) or Problem-Solving Therapy (PST) could
be preferable to insight-oriented psychodynamic therapy.
Our cases had a mean CESD-10 score of 9.5 ± 6.2. A
feature of this clinical-epidemiological study, but not of
these analyes, was the enrollment of control subjects of
similar age (n = 177, 74.9 ± 9.5 years). The mean CESD-10
score of these controls was only 6.7 ± 4.6, a value that was
lower than that of our cases (t test = 3.84, p <0.001), indi-
cating a higher burden of depressive symptoms among
our cases, as has been reported in ET in the past [11–17].
This study should be interpreted within the context of
certain limitations. First, the study was cross-sectional, so
that we are not able to directly address issues of causality.
Second, the sample size was modest and this may have
limited our ability to detect associations. However, the
study was able to detect significant main effects between
several of the key variables. Third, depressive symptoms
were assessed with a brief, validated screening instrument;
it is possible that more in-depth psychiatric assessments
could have uncovered additional associations of interest.
For example, the relationship between symptoms of
anxiety, including social anxiety, and embarrassment and
the relationship between ET and other self-conscious
emotions. In particular, anxiety is also a common feature
of patients with ET [9, 17] and it could impact upon levels
of embarrassment. Future studies could further assess
such relationships. Fourth, we did not collect data on past
history of depression in our cases; such information could
have supplemented the data we collected on current
depressive symptoms.
The study also had several strengths. First, to our
knowledge, it is the only study to have assessed this par-
ticular gap in knowledge and these particular associa-
tions. Second, this was not a retrospective study or chart
review; the study cohort was enrolled prospectively, with
a standardized assessment.
Conclusions
In summary, we found that cases with severe depressive
symptoms had higher embarrassment scores than those
with fewer depressive symptoms, despite the fact that they
had similar levels of tremor severity. Furthermore, greater
tremor severity was not associated with more depressive
symptoms. One interpretation of these data is that depres-
sive symptoms are more than a secondary response to the
tremor in ET; in addition to being clinically important in
themselves, they also seem to drive other important out-
comes such as embarrassment. Earlier treatment of
depressive symptoms in ET patients might be a strategy to
lessen the burden of secondary embarrassment.
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